SUPN · Supernus Pharmaceuticals, Inc. · Debt
$41.21
-0.02 (-0.05%)
At close · Oct 21
Return incl. dividend (before tax)
Market Cap
$2.40B
Shares
58.13M
Volume · Oct 21
1.01M
Avg daily vol (3M)
816.71K
Debt Profile
Completed filing coverage through May 20, 2026Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.
Reported debt balances
Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.
| Reported balance | As of | Amount | Source |
|---|---|---|---|
| Operating lease liabilities | 2026-06-30 | USD 40,170,000 | 10-Q filed 2026-08-03 |
Related accounting measures — not additional borrowingCarrying amounts can reflect issuance costs or discounts. Differences between these measures are not necessarily repayments due within a year.
| |||
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.
Covenants
Covenant terms have not yet been verified for this profile.
The balance figures do not establish whether covenants apply or whether the company complies with them.
Loans, facilities and notes
The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.
Key facts
CIK
1356576
CUSIP
868459108
13F (30d)
42 filings
41 filers
Visit website
Investor relations